A detailed history of Cerity Partners LLC transactions in Natera, Inc. stock. As of the latest transaction made, Cerity Partners LLC holds 86,144 shares of NTRA stock, worth $14.4 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
86,144
Previous 67,828 27.0%
Holding current value
$14.4 Million
Previous $7.35 Million 49.05%
% of portfolio
0.02%
Previous 0.02%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$97.75 - $129.67 $1.79 Million - $2.38 Million
18,316 Added 27.0%
86,144 $10.9 Million
Q2 2024

Aug 13, 2024

SELL
$85.28 - $112.6 $1.99 Million - $2.63 Million
-23,333 Reduced 25.6%
67,828 $7.35 Million
Q1 2024

May 14, 2024

BUY
$59.21 - $92.9 $43,696 - $68,560
738 Added 0.82%
91,161 $8.34 Million
Q4 2023

Jan 26, 2024

BUY
$37.55 - $62.64 $3.1 Million - $5.17 Million
82,514 Added 1043.29%
90,423 $5.66 Million
Q3 2023

Nov 13, 2023

SELL
$43.4 - $62.52 $3.26 Million - $4.69 Million
-75,075 Reduced 90.47%
7,909 $349,000
Q2 2023

Aug 14, 2023

BUY
$47.08 - $55.16 $8,144 - $9,542
173 Added 0.21%
82,984 $4.04 Million
Q1 2023

May 11, 2023

SELL
$36.57 - $58.29 $15,066 - $24,015
-412 Reduced 0.5%
82,811 $4.6 Million
Q4 2022

Feb 15, 2023

BUY
$34.17 - $47.91 $2.84 Million - $3.99 Million
83,223 New
83,223 $3.34 Million
Q1 2022

Apr 25, 2022

SELL
$30.32 - $91.33 $145,354 - $437,836
-4,794 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$86.26 - $119.0 $10,782 - $14,875
125 Added 2.68%
4,794 $446,000
Q3 2021

Oct 25, 2021

SELL
$100.17 - $126.36 $756,283 - $954,018
-7,550 Reduced 61.79%
4,669 $520,000
Q2 2021

Aug 11, 2021

BUY
$86.05 - $119.72 $4,560 - $6,345
53 Added 0.44%
12,219 $1.39 Million
Q1 2021

Aug 11, 2021

BUY
$91.47 - $124.36 $690,598 - $938,918
7,550 Added 163.56%
12,166 $1.24 Million
Q1 2021

May 12, 2021

BUY
$91.47 - $124.36 $422,225 - $574,045
4,616 New
4,616 $469,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Cerity Partners LLC Portfolio

Follow Cerity Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cerity Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cerity Partners LLC with notifications on news.